Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis
- PMID: 22174919
- PMCID: PMC3236763
- DOI: 10.1371/journal.pone.0028882
Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis
Abstract
Background: Aberrant methylation of promoter DNA and transcriptional repression of specific tumor suppressor genes play an important role in carcinogenesis. Recently, many studies have investigated the association between cigarette smoking and p16(INK4α) gene hypermethylation in lung cancer, but could not reach a unanimous conclusion.
Methods and findings: Nineteen cross-sectional studies on the association between cigarette smoking and p16(INK4α) methylation in surgically resected tumor tissues from non-small cell lung carcinoma (NSCLC) patients were identified in PubMed database until June 2011. For each study, a 2×2 cross-table was extracted. In total, 2,037 smoker and 765 nonsmoker patients were pooled with a fixed-effects model weighting for the inverse of the variance. Overall, the frequency of p16(INK4α) hypermethylation was higher in NSCLC patients with smoking habits than that in non-smoking patients (OR = 2.25, 95% CI = 1.81-2.80). The positive association between cigarette smoking and p16(INK4α) hypermethylation was similar in adenocarcinoma and squamous-cell carcinoma. In the stratified analyses, the association was stronger in Asian patients and in the studies with larger sample sizes.
Conclusion: Cigarette smoking is positively correlated to p16(INK4α) gene hypermethylation in NSCLC patients.
Conflict of interest statement
Figures






Similar articles
-
Cigarette Smoking, BPDE-DNA Adducts, and Aberrant Promoter Methylations of Tumor Suppressor Genes (TSGs) in NSCLC from Chinese Population.Cancer Invest. 2016;34(4):173-80. doi: 10.3109/07357907.2016.1156689. Epub 2016 Apr 4. Cancer Invest. 2016. PMID: 27042875
-
CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.Diagn Mol Pathol. 2012 Dec;21(4):207-13. doi: 10.1097/PDM.0b013e31825554b2. Diagn Mol Pathol. 2012. PMID: 23111194
-
Assessment of the prognostic value of methylation status and expression levels of FHIT, GSTP1 and p16 in non-small cell lung cancer in Egyptian patients.Asian Pac J Cancer Prev. 2014;15(10):4281-7. doi: 10.7314/apjcp.2014.15.10.4281. Asian Pac J Cancer Prev. 2014. PMID: 24935385
-
The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review.Sci Rep. 2016 Jan 22;6:19303. doi: 10.1038/srep19303. Sci Rep. 2016. PMID: 26796853 Free PMC article. Review.
-
Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis.Drug Des Devel Ther. 2015 Jun 3;9:2855-65. doi: 10.2147/DDDT.S76358. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26082616 Free PMC article.
Cited by
-
Can social adversity alter the epigenome, trigger oral disease, and affect future generations?Ir J Med Sci. 2024 Oct;193(5):2597-2606. doi: 10.1007/s11845-024-03697-3. Epub 2024 May 14. Ir J Med Sci. 2024. PMID: 38740675 Free PMC article. Review.
-
New P16 Expression Criteria Predict Lymph Node Metastasis in Patients With Non-small Cell Lung Cancer.In Vivo. 2019 Nov-Dec;33(6):1885-1892. doi: 10.21873/invivo.11682. In Vivo. 2019. PMID: 31662516 Free PMC article.
-
Autophagic protein Beclin 1 serves as an independent positive prognostic biomarker for non-small cell lung cancer.PLoS One. 2013 Nov 15;8(11):e80338. doi: 10.1371/journal.pone.0080338. eCollection 2013. PLoS One. 2013. PMID: 24260370 Free PMC article.
-
Association between P(16INK4a) promoter methylation and non-small cell lung cancer: a meta-analysis.PLoS One. 2013;8(4):e60107. doi: 10.1371/journal.pone.0060107. Epub 2013 Apr 5. PLoS One. 2013. PMID: 23577085 Free PMC article.
-
CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer.J Thorac Oncol. 2013 Nov;8(11):1378-88. doi: 10.1097/JTO.0b013e3182a46c0c. J Thorac Oncol. 2013. PMID: 24077454 Free PMC article.
References
-
- Ministry of Health of the People,s Republic of China. The cause of death in China: the third retrospective sample survey. Beijing: Peking Union Medical College Press; 2008.
-
- Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002;346:92–98. - PubMed
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249. - PubMed
-
- Villeneuve PJ, Mao Y. Lifetime probability of developing lung cancer, by smoking status, Canada. Can J Public Health. 1994;85:385–388. - PubMed
-
- Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers–a different disease. Nat Rev Cancer. 2007;7:778–790. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical